These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Maternal serum unconjugated oestriol and human chorionic gonadotrophin levels in pregnancies with insulin-dependent diabetes: implications for screening for Down's syndrome. Wald NJ; Cuckle HS; Densem JW; Stone RB Br J Obstet Gynaecol; 1992 Jan; 99(1):51-3. PubMed ID: 1372176 [TBL] [Abstract][Full Text] [Related]
26. Screening of maternal serum for fetal Down's syndrome in the first trimester. Haddow JE; Palomaki GE; Knight GJ; Williams J; Miller WA; Johnson A N Engl J Med; 1998 Apr; 338(14):955-61. PubMed ID: 9521983 [TBL] [Abstract][Full Text] [Related]
27. Maternal serum unconjugated oestriol and human chorionic gonadotrophin levels in twin pregnancies: implications for screening for Down's syndrome. Wald N; Cuckle H; Wu TS; George L Br J Obstet Gynaecol; 1991 Sep; 98(9):905-8. PubMed ID: 1716981 [TBL] [Abstract][Full Text] [Related]
29. Serum markers for Down's syndrome in women who have had in vitro fertilisation: implications for antenatal screening. Wald NJ; White N; Morris JK; Huttly WJ; Canick JA Br J Obstet Gynaecol; 1999 Dec; 106(12):1304-6. PubMed ID: 10609726 [TBL] [Abstract][Full Text] [Related]
39. Preliminary evidence for associations between second-trimester human chorionic gonadotropin and unconjugated oestriol levels with pregnancy outcome in Down syndrome pregnancies. Benn PA Prenat Diagn; 1998 Apr; 18(4):319-24. PubMed ID: 9602476 [TBL] [Abstract][Full Text] [Related]